Italian pharmaceutical company buys rights to immunotherapy from Sanofi

Italy's Recordati buys the rights to a treatment for the rare autoimmune disease cold agglutinin disease (CAD).

Tablet treatment for hair loss approved in the USA

The US Drug Administration has given a thumbs up for the first tablet treatment for spotty hair loss.

Patentutgångar tvingar BMS till nytt sparpaket

Läkemedelsjätten Bristol Myers Squibb planerar nya stora nedskärningar mindre än ett år efter det förra sparpaketet.

RFK Jr: I september vet vi vad som orsakar autism

USA ska identifiera orsaken till autism – och det ska vara gjort till september i år. Det säger USA:s hälsominister Robert F. Kennedy Jr., som därmed sätter en ...

The fast route to a safe insulin pen

Diabetes is on the rise worldwide with around ten million people developing the disease every year. Demand for insulin pens allowing patients to self-medicate i...

AstraZeneca to use American AI platform for cancer trials

In a collaboration AstraZeneca will use an AI model from Israeli-American biotech Immunai to streamline its clinical trials in cancer.

Astra Zeneca-medarbetare gripna i Kina

Fem nuvarande eller tidigare anställda hos Astra Zeneca har gripits av kinesisk polis, misstänkta för smuggling och överträdelse av Kinas dataskyddslagar

MVA:s CEO: “Our investments should improve people´s everyday lives”

Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.

Astra Zeneca dumpar projekt inom blodsjukdomar – tar miljardsmäll

Astra Zeneca lägger ner ett läkemedelsprojekt inom sällsynta blodsjukdomar och tar en avsevärd ekonomisk smäll: en nedskrivning på 753 miljoner dollar, motsvara...

Quotient Sciences Limited

Festo Expands its Portfolio with Multilayer Manifolds

Manufacturers of medical and laboratory equipment now receive solutions from a single source

Clinigen Clinical Supplies Management GmbH

Joy at Egetis after positive CHMP opinion – ”The single most important milestone”

Stockholm-based Egetis Therapeutics has received a positive CHMP opinion for Emcitate, which could become the first approved treatment for the rare disease MCT8 deficiency."

Immedica högt på listan över Sveriges bästa arbetsplatser

Stockholmsbaserade Immedica Pharma hamnar tvåa på listan över Sveriges bästa arbetsplatser i kategorin medelstora organisationer. Även andra läkemedelsföretag f...

Metabolon

From spin-off to phase II

”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.

Spotify och vaccinbråket – detta har hänt

En superhajpad podcast, ett öppet brev från 270 amerikanska hälsoexperter och en protesterande gammal rockare med rutig flanellskjorta har toppat tidningar och ...

High-performance Slide Scanner for Fluorescence, Brightfield and Polarization

ZEISS Axioscan 7.

Orbán's extended arm becomes health commissioner in the EU

Hungarian Olivér Várhelyi may soon become the most influential official for the healthcare and pharmaceutical industry in the EU. Várhelyi, who is close to Hung...

Biosimilars bring price pressure, but are they sufficiently used?

When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

The First Multi-Technology System from ZEISS

Microscope and measuring machine in one.

Precision and accuracy in liquid handling

How to evaluate and optimize liquid handling performance

Merck Life Science A/S